Literature DB >> 17408647

Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement.

Pavel Strnad1, Masaru Harada, Matthew Siegel, Robert A Terkeltaub, Robert M Graham, Chaitan Khosla, M Bishr Omary.   

Abstract

BACKGROUND & AIMS: Mallory body (MB) inclusions are a characteristic feature of several liver disorders and share similarities with cytoplasmic inclusions observed in neural diseases and myopathies. MBs consist primarily of keratins 8 and 18 (K8/K18), require a K8-greater-than-K18 ratio for their formation, and contain glutamine-lysine cross-links generated by transglutaminase (TG). We hypothesized that protein transamidation is essential for MB formation.
METHODS: Because TG2 is the most abundant hepatocyte TG, we tested our hypothesis using TG2(-/-) and their wild-type counterpart mice fed 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC), an established MB inducer. Keratin cross-linking was further examined using recombinant proteins or transgenic mice that overexpress K8 or K18.
RESULTS: TG2(-/-) livers have markedly reduced TG2 activity as compared with TG2(+/+) livers. The DDC-fed TG2(-/-) mice have dramatic decreases in MB formation and liver hypertrophy response as contrasted with DDC-fed TG2(+/+) mice. Despite similar hepatocellular damage, TG2(-/-) mice had more gallstones, jaundice, and ductal proliferation than wild-type mice. Inhibition of MB formation in TG2(-/-) mice was associated with marked attenuation of ubiquitination and K8-containing protein cross-linking. MB formation and resolution paralleled the generation then disappearance of cross-linked K8, respectively. K8 is a preferential TG2 substrate when compared to K18, as examined in vitro or in DDC-fed transgenic mice that overexpress K8 or K18.
CONCLUSIONS: We demonstrate an essential role for TG2 in determining injury-mediated liver enlargement and the necessity of K8 and TG2 for generating cross-linked keratins and MBs. The role of TG in inclusion formation might extend to nonkeratin intermediate filament protein-related diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408647     DOI: 10.1053/j.gastro.2007.02.020

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

Review 1.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

2.  Keratin 8 phosphorylation regulates its transamidation and hepatocyte Mallory-Denk body formation.

Authors:  Raymond Kwan; Shinichiro Hanada; Masaru Harada; Pavel Strnad; Daniel H Li; M Bishr Omary
Journal:  FASEB J       Date:  2012-02-23       Impact factor: 5.191

3.  Aging modulates susceptibility to mouse liver Mallory-Denk body formation.

Authors:  Shinichiro Hanada; Masaru Harada; Mitsuhiko Abe; Jun Akiba; Masahiro Sakata; Raymond Kwan; Eitaro Taniguchi; Takumi Kawaguchi; Hironori Koga; Eisuke Nagata; Takato Ueno; Michio Sata
Journal:  J Histochem Cytochem       Date:  2012-04-03       Impact factor: 2.479

Review 4.  Intermediate filament proteins of digestive organs: physiology and pathophysiology.

Authors:  M Bishr Omary
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-03-30       Impact factor: 4.052

5.  Oxidative stress, Nrf2 and keratin up-regulation associate with Mallory-Denk body formation in mouse erythropoietic protoporphyria.

Authors:  Amika Singla; David S Moons; Natasha T Snider; Elizabeth R Wagenmaker; V Bernadene Jayasundera; M Bishr Omary
Journal:  Hepatology       Date:  2012-04-25       Impact factor: 17.425

Review 6.  Post-translational modifications of intermediate filament proteins: mechanisms and functions.

Authors:  Natasha T Snider; M Bishr Omary
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

7.  Keratin overexpression levels correlate with the extent of spontaneous pancreatic injury.

Authors:  Diana M Toivola; Ikuo Nakamichi; Pavel Strnad; Sara A Michie; Nafisa Ghori; Masaru Harada; Karin Zeh; Robert G Oshima; Helene Baribault; M Bishr Omary
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

Review 8.  Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.

Authors:  William Bains
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

9.  Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1.

Authors:  Hideki Tatsukawa; Yayoi Fukaya; Gordon Frampton; Antonio Martinez-Fuentes; Kenji Suzuki; Ting-Fang Kuo; Keisuke Nagatsuma; Kentaro Shimokado; Masataka Okuno; Jian Wu; Siiri Iismaa; Tomokazu Matsuura; Hidekazu Tsukamoto; Mark A Zern; Robert M Graham; Soichi Kojima
Journal:  Gastroenterology       Date:  2009-01-14       Impact factor: 22.682

10.  Assays for Posttranslational Modifications of Intermediate Filament Proteins.

Authors:  Natasha T Snider; M Bishr Omary
Journal:  Methods Enzymol       Date:  2015-11-06       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.